Determining the minimum important differences for field walking tests in adults with long-term conditions: a systematic review and meta-analysis.

IF 9 1区 医学 Q1 RESPIRATORY SYSTEM
European Respiratory Review Pub Date : 2025-05-28 Print Date: 2025-04-01 DOI:10.1183/16000617.0198-2024
Enya Daynes, Ruth E Barker, Amy V Jones, Jessica A Walsh, Claire M Nolan, William D-C Man, Sally J Singh, Neil J Greening, Linzy Houchen-Wolloff, Rachael A Evans
{"title":"Determining the minimum important differences for field walking tests in adults with long-term conditions: a systematic review and meta-analysis.","authors":"Enya Daynes, Ruth E Barker, Amy V Jones, Jessica A Walsh, Claire M Nolan, William D-C Man, Sally J Singh, Neil J Greening, Linzy Houchen-Wolloff, Rachael A Evans","doi":"10.1183/16000617.0198-2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>The minimum important difference (MID) for field walking tests aims to improve interpretation of outcomes, but the volume and heterogeneity of MIDs for these tests is challenging. We aimed to determine the MID for the 6-min walk distance (6MWD), incremental shuttle walk test (ISWT) and endurance shuttle walk test (ESWT) in adults with long-term conditions.</p><p><strong>Methods: </strong>This systematic review included studies that generated a MID using an anchor-based approach in patients with long-term conditions for the 6MWD, ISWT or ESWT field walking tests. Studies were screened and data extracted by independent reviewers. Meta-analyses were performed using RevMan.</p><p><strong>Results: </strong>42 studies were included in the analyses, involving n=13 949 participants. Of these, 12 studies involving exercise as an intervention were included in the meta-analyses to produce MIDs, presented as mean (95% confidence interval). The MID for the 6MWD was 25 m (24-26 m) for respiratory conditions, 23 m (8-37 m) for cardiac conditions and 37 m (26-49 m) for neurological/musculoskeletal conditions. The MID for the ISWT was 48 m (39-57 m) for respiratory conditions and 70 m (55-85 m) for cardiac conditions. The MID for ESWT in COPD was 159 s (94-224 s). The pooled MID across conditions within exercise interventions was 26 m (22-40 m) for the 6MWD and 53 m (44-62 m) for the ISWT, with reasonable heterogeneity (I<sup>2</sup>=48% and I<sup>2</sup>=47%, respectively).</p><p><strong>Conclusion: </strong>We propose new MIDs for exercise interventions using anchor-based methodology in long‑term conditions for the 6MWD, ISWT and ESWT. These can be used internationally for meta‑analyses where studies have used different field walking tests, to optimise trial sample size calculations, and for clinical service benchmarking.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"34 176","pages":""},"PeriodicalIF":9.0000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12117381/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Review","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/16000617.0198-2024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"Print","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: The minimum important difference (MID) for field walking tests aims to improve interpretation of outcomes, but the volume and heterogeneity of MIDs for these tests is challenging. We aimed to determine the MID for the 6-min walk distance (6MWD), incremental shuttle walk test (ISWT) and endurance shuttle walk test (ESWT) in adults with long-term conditions.

Methods: This systematic review included studies that generated a MID using an anchor-based approach in patients with long-term conditions for the 6MWD, ISWT or ESWT field walking tests. Studies were screened and data extracted by independent reviewers. Meta-analyses were performed using RevMan.

Results: 42 studies were included in the analyses, involving n=13 949 participants. Of these, 12 studies involving exercise as an intervention were included in the meta-analyses to produce MIDs, presented as mean (95% confidence interval). The MID for the 6MWD was 25 m (24-26 m) for respiratory conditions, 23 m (8-37 m) for cardiac conditions and 37 m (26-49 m) for neurological/musculoskeletal conditions. The MID for the ISWT was 48 m (39-57 m) for respiratory conditions and 70 m (55-85 m) for cardiac conditions. The MID for ESWT in COPD was 159 s (94-224 s). The pooled MID across conditions within exercise interventions was 26 m (22-40 m) for the 6MWD and 53 m (44-62 m) for the ISWT, with reasonable heterogeneity (I2=48% and I2=47%, respectively).

Conclusion: We propose new MIDs for exercise interventions using anchor-based methodology in long‑term conditions for the 6MWD, ISWT and ESWT. These can be used internationally for meta‑analyses where studies have used different field walking tests, to optimise trial sample size calculations, and for clinical service benchmarking.

确定患有长期疾病的成人现场行走试验的最小重要差异:系统回顾和荟萃分析。
重要性:野外行走试验的最小重要差异(MID)旨在改善对结果的解释,但这些试验的最小重要差异的数量和异质性具有挑战性。我们的目的是确定成人长期疾病的6分钟步行距离(6MWD)、增量穿梭步行测试(ISWT)和耐力穿梭步行测试(ESWT)的MID。方法:本系统综述纳入了在长期患有6MWD、ISWT或ESWT野外行走测试的患者中使用锚定方法产生MID的研究。研究经过筛选,数据由独立审稿人提取。meta分析采用RevMan软件。结果:42项研究纳入分析,涉及n= 13949名受试者。其中,12项将运动作为干预措施的研究被纳入meta分析,以产生mid,以平均值表示(95%置信区间)。6MWD的MID为呼吸疾病25米(24-26米),心脏疾病23米(8-37米),神经/肌肉骨骼疾病37米(26-49米)。呼吸条件下ISWT的MID为48米(39-57米),心脏条件下为70米(55-85米)。COPD患者ESWT的MID为159 s (94-224 s)。在运动干预中,6MWD组和ISWT组的混合MID分别为26 m (22-40 m)和53 m (44-62 m),具有一定的异质性(I2分别为48%和47%)。结论:我们为6MWD、ISWT和ESWT的长期条件下使用基于锚定的方法提出了新的运动干预mid。这些数据可以在国际上用于荟萃分析,其中研究使用了不同的实地行走测试,以优化试验样本量计算,并用于临床服务基准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Respiratory Review
European Respiratory Review Medicine-Pulmonary and Respiratory Medicine
CiteScore
14.40
自引率
1.30%
发文量
91
审稿时长
24 weeks
期刊介绍: The European Respiratory Review (ERR) is an open-access journal published by the European Respiratory Society (ERS), serving as a vital resource for respiratory professionals by delivering updates on medicine, science, and surgery in the field. ERR features state-of-the-art review articles, editorials, correspondence, and summaries of recent research findings and studies covering a wide range of topics including COPD, asthma, pulmonary hypertension, interstitial lung disease, lung cancer, tuberculosis, and pulmonary infections. Articles are published continuously and compiled into quarterly issues within a single annual volume.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信